CN104366511A - High-density reinforced protein oral liquid - Google Patents
High-density reinforced protein oral liquid Download PDFInfo
- Publication number
- CN104366511A CN104366511A CN201410520351.5A CN201410520351A CN104366511A CN 104366511 A CN104366511 A CN 104366511A CN 201410520351 A CN201410520351 A CN 201410520351A CN 104366511 A CN104366511 A CN 104366511A
- Authority
- CN
- China
- Prior art keywords
- protein
- nitrogen
- vitamin
- oligopeptide
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 37
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 37
- 239000007788 liquid Substances 0.000 title claims abstract description 27
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 41
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 41
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 33
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 16
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 16
- 239000011718 vitamin C Substances 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940046009 vitamin E Drugs 0.000 claims abstract description 15
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 15
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 13
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 13
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 13
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 13
- 102000008186 Collagen Human genes 0.000 claims description 34
- 108010035532 Collagen Proteins 0.000 claims description 34
- 229920001436 collagen Polymers 0.000 claims description 34
- 238000005728 strengthening Methods 0.000 claims description 22
- 239000002502 liposome Substances 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 9
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 102000008934 Muscle Proteins Human genes 0.000 claims description 2
- 108010074084 Muscle Proteins Proteins 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 5
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 120
- 229910052757 nitrogen Inorganic materials 0.000 description 60
- 235000018102 proteins Nutrition 0.000 description 27
- 239000000243 solution Substances 0.000 description 26
- 241000700159 Rattus Species 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 238000000034 method Methods 0.000 description 14
- 238000003860 storage Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- 235000021590 normal diet Nutrition 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000013589 supplement Substances 0.000 description 10
- 108010028690 Fish Proteins Proteins 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 241000251468 Actinopterygii Species 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 235000012907 honey Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 5
- 229920000053 polysorbate 80 Polymers 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000022558 protein metabolic process Effects 0.000 description 4
- 241000237858 Gastropoda Species 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000019621 digestibility Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 102000004400 Aminopeptidases Human genes 0.000 description 2
- 108090000915 Aminopeptidases Proteins 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 208000020084 Bone disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000242873 Scopolia Species 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940120612 zinc gluconate 5 mg Drugs 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000010240 Paullinia pinnata Nutrition 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 229940023492 oral liquid product Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to a high-density reinforced protein oral liquid and belongs to the technical field of nutrient supplements. The high-density reinforced protein oral liquid comprises 30-35% of protein oligopeptide (MW<5000D), reinforces nanoliposome vitamin C, nanoliposome vitamin E and zinc gluconate and guarantees vitamin stability. The high-density reinforced protein oral liquid improves protein and vitamin absorptivity and bioavailability, and can be widely used for weak patients, patients before and after operation, and patients with a plurality of clinical diseases.
Description
Technical field
The present invention relates to a kind of high concentration strengthening protein oral liquor, belong to nutrient prime replenisher field.
Background technology
The standard GB/T 29922-2013--special medicine purposes formula food general rule that on July 1st, 2014 implements, this food indicating that a class is new is about to come on stage.Special medicine purposes formula food (Food forSpecial Medical Purposes, FSMP) refer in order to satisfied feed is limited, Disorder of Digestion and A orption, metabolic disorder or particular disease states crowd to the special requirement of nutrient or meals, the formula food that special processing is formulated.
What special medicine purposes formula food adopted is standardized science, equilibrium, comprehensively nutrient formulation, long-term or short-term can meet the nutritional need of patient easily.Special medicine purposes formula food is the based food between bread and cheese and medicine, based on powdery or liquid state and volume is larger, because it contains various nutritional labeling and nutritional support effect clinically, the usual category being included in food in the world.
A large amount of evidences and clinical practice show, nutritional support has a very important role for the result for the treatment of of patient and rehabilitation.Just this series products is generally used clinically abroad as far back as last century eight, the nineties, very extensive in developed country's application such as European Countries, the U.S., Canada, Australia, New Zealand, Japan, and in succession formulated the standard of special medicine purposes formula food and relevant supporting management measure, be product indispensable in clinical treatment.Improving nutrition situation, promoting patients ' recovery, shortening the hospital stays, saving the aspects such as payment for medical care and played great function.This series products has been listed in medical insurance reimbursement scope by many countries.
In China, this series products is clinical and blank that is market always, but along with socioeconomic development, the arriving of aging society, medical expense and medical insurance increasing pressure large, people, to the growing interest of nutrient knowledge and Nutritional Status, add information interchange both domestic and external, and increasing nutritionist, doctor, clinical nutrition teacher and patient itself payes attention to the nutrition condition during disease.Chinese is populous, introduces this series products, will improve part chronic, plays a positive role in the disease treatment of the special populations such as old age, children and pregnant woman.
It is reported, many patients in intensive care unit cause life exhausted because of the shortage of nutrition.Statistics show, and in hospital of western countries, the patient of 25%-30% causes because of malnutrition, and Asia is about 40%.Wherein, nutrition worsens more in the while in hospital more the people of 70%.In Europe, underfed cost reaches 11,000,000,000 Euros, is mainly derived from malnutrition and complication thereof, hospitalization cost and recovers the economic loss that the undesirable secondary disease brought causes.Therefore, develop the nutraceutical of high-quality, patient can be helped to recover physical efficiency, even change because of disease that gene mutation causes, thus make patient obtain better result for the treatment of, get well with the shorter time.
A kind of oral liquid containing calcium and proteins and preparation technology thereof is provided in prior art, described oral liquid is stuck with paste extract, multi-medicament extract and flavouring refined honey liquid by bone and formed, described preparation technology comprises and prepares bone paste extract respectively, multi-medicament extract and flavouring refined honey liquid, then above-mentioned three kinds of solution are prepared burden in proportion, through high-temp sterilizing, be cooled to room temperature, filter institute obtain filtrate and make.This kind of oral liquid has effect that beneficial marrow strengthens bone, qi-supplementing, blood-engendering, cures mainly woman gestationperiod, lactation, children's, student and old man's calcium deficiency, the disease of anaemia and health-care effect.
A kind of biological collagen oral liquor and preparation method thereof is additionally provided in prior art, the method step: 1) biological collagen processed: choosing is healthy, virus-free, fragrant pig within 3 months monthly ages, clean, slaughter, peeling → unhairing, degrease layer → sterilization, sterilization → pigskin water cleans up → physiological saline boiling pigskin, treat its one-tenth gelatin → molecular weight be that 5 ~ 80,000 collagens carry out high-temperature acidic degraded, pH value 4 ~ 6, by collagen transient heating to 180 ~ 250 DEG C, be cooled to 15 ~ 25 DEG C immediately, less than the ten thousand → filtration of its molecular weight and molecular weight to 1 is purified, be separated and remove grease, obtain collagen, 2) biological collagen oral liquor processed: get weight concentration 5 ~ 15% collagen liquid 100 weight portion, calcium salt 1.5 ~ 5 weight portion stirs evenly, mixed liquor filters, and sterilizing, obtains biological collagen oral liquor.This oral liquid has a good therapeutic effect to bone split, disconnected symphysis and other osteopathy; Also tool beauty treatment, the strong health-care effect such as skin, develop immunitypty.
A kind of collagen oral liquid is additionally provided in prior art, belong to field of health drinks, it is characterized in that: adopt Isin glue collagen peptide, vitamin E, vitamin C, arginine, isoflavones, Tea Polyphenols, beta carotene and apple polyphenol to be primary raw material, essence and water is added in composition, collagen peptide in composition is micromolecular collagen, effective increase absorbs, and composition adopts raw-food material simultaneously, and edible safety is reliable.
A kind of snail protein oral liquor is additionally provided in prior art, containing snail protein 15 grams, cephalo Chinese caterpillar fungus 50 grams, fruit of Chinese magnoliavine 80-100 gram, 60 grams, almond, scopolia acutangula 5-10 gram, honey 200 milliliters, its preparation technology is by Homogeneous phase mixing such as snail protein hydrolysis liquid, the immersion liquid of five tastes subflow, cephalo worm extract, almond juice, scopolia acutangula extract, honey, and after filtration, the technique such as sterilizing makes.Be cough for treatment consumptive disease to breathe heavily and establish, have relieving cough and asthma, effect of nourishing lung and kidney, often interval is taken, and has the health-care effect of strong physique.
Additionally provide the collagen oral liquid that a kind of bioavilability improves in prior art, comprise the collagen of biological absorbable and increase the stabilizing agent of collagen dispersion.Collagen oral liquid of the present invention contains the collagen of the biological absorbable of high level, and its molecular weight is 2500 ~ 3500D, and content is not less than 10% (g/ml).The stabilizing agent of the increase collagen dispersion that the present invention adopts is selected from hydroxypropyl methylcellulose, sodium alginate, sodium carboxymethylcellulose, methylcellulose, xanthans and HLB value 7 ~ 13 and contains the nonionic surface active agent of aliphatic chain.Collagen oral liquid of the present invention can be used for improving skin and preventing bone and joint diseases.
Additionally provide a kind of collagen oral liquid in prior art, comprise the raw material components of following weight portion: 100 parts, collagen marine oligopeptide powder, tocopherol 0.5-1.0 part, Catergen .5-3.5 part, arginine 0.5-1.0 part, AJC 60-70 part, honey 5-10 part, beta carotene 0.005-0.01 part, Sucralose 0.1-0.2 part, malic acid 6-8 part, polyoxyethylene sorbitan monooleate 2-3 part, xanthans 0.8-1.0 part and water 700-720 part; In preparation process, in advance by pre-emulsification embedding process, by tocopherol, apple concentrate and polyoxyethylene sorbitan monooleate carry out pre-treatment, form tocopherol embedding micellar solution; The even clear of oral liquid product of preparation, safe and reliable, have no side effect, and through the clinical testing of bodily fuctions, have the advantages that to improve skin water supplement function.
Additionally provide a kind of collagen peptide-oligosacchargel-aloe gel-aloe liquid beverage in prior art, it comprises component: collagen peptide, compound sugar, inspissated juice or dried fruit juice, plant extracts and water; Wherein, described plant extracts comprises aloe gel; Percentage, the content of each component is: collagen peptide 9% ~ 13%; Compound sugar 3% ~ 10%; Inspissated juice/dried fruit juice 1% ~ 3.5%; Plant extracts 2% ~ 7%; Surplus is water.The interior hydroxyproline of product of the present invention, oligopeptide and aloe polysaccharide can play increase skin elasticity at human body, reduce wrinkle, comprehensive cosmetology effect, experiment proves, drink of the present invention has conspicuousness effect to raising moisture content of skin, solves common collagen oral liquid and can not play the problem of comprehensively improving looks.
Additionally provide a kind of with mammal skin collagen in prior art, and add the Biofunctional beautifying health oral liquid of active SOD, the collagen that human body skin day by day reduces can be supplemented, there is conditioner body surface chrotoplast metabolic function, anti-ageing at raising body, recover skin elasticity and wettability, recover the aspects such as human body appearance, have obvious effect; And provide the method that the preparation of collagen oral liquid and contained mammal skin collagen extract, there is simple process, with short production cycle, yield is high, cost is low, be therefore easy to suitability for industrialized production and apply
There are the following problems for above-mentioned prior art: the molecular weight of (1) albumen is too large, and elderly and infirm, digestion and absorption function infull person, patients after surgery etc. is lower to its absorptivity; (2) lack strengthening composition, though or have enhanced nutrient, its absorptivity is low, the aqueous solution is unstable.
Summary of the invention
For overcoming the shortcoming existed in prior art, goal of the invention of the present invention is to provide a kind of high concentration strengthening protein oral liquor, and its absorptivity is high.
For realizing described goal of the invention, the invention provides a kind of strengthening protein oral liquor, it is characterized in that, comprising: containing albumen oligopeptide, nano liposomes vitamin C, nano liposomes vitamin E and zinc gluconate.
Preferably, every 100 milliliters of oral liquids contain albumen oligopeptide, the vitamin E of 0.5 ~ 300mg, the vitamin C of 10 ~ 500mg, the zinc gluconate of 5-20mg of 30 ~ 35g.
Preferably, albumen oligopeptide molecular weight < 5000D.
Preferably, albumen oligopeptide is the hydrolysate of animal collagen, animal muscle protein or lactalbumin.
Compared with prior art, high concentration strengthening protein oral liquor absorptivity provided by the invention is high.
Detailed description of the invention
Below in conjunction with detailed description of the invention, the present invention is elaborated.
Embodiment one:
The high concentration strengthening protein oral liquor that first embodiment of the invention provides, its component comprises: every 1000mL is containing albumen oligopeptide 300g, nano liposomes vitamin E 1000mg, vitamin C 500mg, zinc gluconate 20mg.
High concentration strengthening protein oral liquor prepares by the following method:
S01: phosphatidase 5 g, cholesterol 1g, tween 1g (Tween 80) are dissolved in 30ml ethanol (or chloroform, methyl alcohol or carrene etc.), then eggplant-shape bottle is put into, on water-bath evaporimeter (bath temperature 55 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution A;
S02: add vitamin E in solution A, 1000mg, on water-bath evaporimeter (bath temperature 55 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution B
S03: take vitamin C 500g, zinc gluconate 20mg and to be dissolved in 10ml distilled water and (bath temperature 55 DEG C ± 1 DEG C) constantly stirs and obtain water-soluble solution C on water-bath evaporimeter;
S04: water-soluble solution C is mixed with solution B, and (bath temperature 55 DEG C ± 1 DEG C) continuous stirring obtains soluble solution D on water-bath evaporimeter;
S05: to solution D reduction vaporization to remove desolventizing;
S06: use spy formula Ultrasound Instrument to make the abundant aquation 20-120 minute of lipid membrane under ice-water bath condition, until become transparent to emulsion;
S07: use Microfluidizer under 100MPa pressure to emulsion breast even 2 times;
S08: add distilled water to 800ml;
S09: add collagen oligopeptide 300g, on water-bath evaporimeter (bath temperature 55 DEG C ± 1 DEG C), is stirred to dissolving;
S10: add distilled water to 1000ml on water-bath evaporimeter (bath temperature 55 DEG C ± 1 DEG C), stir, then filter packing, obtain and comprise the albumen oligopeptide (MW < 5000D) that concentration is 30%, and strengthening is with the strengthening protein oral liquor of nano liposomes vitamin C, nano liposomes vitamin E and zinc gluconate.
Embodiment two
The high concentration strengthening protein oral liquor that second embodiment of the invention provides, its component comprises: every 1000mL is containing albumen oligopeptide 350g, nano liposomes vitamin E 3g vitamin C 5g zinc gluconate 200mg.
Embodiment two provides high concentration to strengthen protein oral liquor and prepares by the following method:
S01: phosphatidase 5 g, cholesterol 1g, tween 1g (Tween 80) are dissolved in 30ml ethanol (or chloroform, methyl alcohol or carrene etc.), then eggplant-shape bottle is put into, on water-bath evaporimeter (bath temperature 45 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution A;
S02: add vitamin E in solution A, 3g, on water-bath evaporimeter (bath temperature 45 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution B
S03: take vitamin C 5g, zinc gluconate 200mg and to be dissolved in 10ml distilled water and (bath temperature 45 DEG C ± 1 DEG C) constantly stirs and obtain water-soluble solution C on water-bath evaporimeter;
S04: water-soluble solution C is mixed with solution B, and (bath temperature 45 DEG C ± 1 DEG C) continuous stirring obtains soluble solution D on water-bath evaporimeter;
S05: to solution D reduction vaporization to remove desolventizing;
S06: use spy formula Ultrasound Instrument to make the abundant aquation of lipid membrane 80 minutes under ice-water bath condition, until become transparent to emulsion;
S07: use Microfluidizer under 100MPa pressure to emulsion breast even 6 times;
S08: add distilled water to 800ml;
S09: add collagen oligopeptide 300g, on water-bath evaporimeter (bath temperature 45 DEG C ± 1 DEG C), is stirred to dissolving;
S10: add distilled water to 1000ml on water-bath evaporimeter (bath temperature 45 DEG C ± 1 DEG C), stir, then filter packing, obtain and comprise the albumen oligopeptide (MW < 5000D) that concentration is 35%, and strengthening is with the strengthening protein oral liquor of nano liposomes vitamin C, nano liposomes vitamin E and zinc gluconate.
Embodiment three
The high concentration strengthening protein oral liquor that the embodiment of the present invention three provides, every 1000mL is containing albumen oligopeptide 320g, nano liposomes vitamin E 5mg, vitamin C 100mg, zinc gluconate 5mg.
The high concentration strengthening protein oral liquor that embodiment three provides prepares by the following method:
S01: phosphatidase 5 g, cholesterol 1g, tween 1g (Tween 80) are dissolved in 30ml ethanol (or chloroform, methyl alcohol or carrene etc.), then eggplant-shape bottle is put into, on water-bath evaporimeter (bath temperature 50 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution A;
S02: add the E 5mg that supports one's family in solution A, on water-bath evaporimeter (bath temperature 50 DEG C ± 1 DEG C), is stirred to and dissolves to obtain solution B
S03: take vitamin C 100mg, zinc gluconate 5mg and to be dissolved in 10ml distilled water and (bath temperature 45 DEG C ± 1 DEG C) constantly stirs and obtain water-soluble solution C on water-bath evaporimeter;
S04: water-soluble solution C is mixed with solution B, and (bath temperature 50 DEG C ± 1 DEG C) continuous stirring obtains soluble solution D on water-bath evaporimeter;
S05: to solution D reduction vaporization to remove desolventizing;
S06: use spy formula Ultrasound Instrument to make the abundant aquation 20-60 minute of lipid membrane under ice-water bath condition, until become transparent to emulsion;
S07: use Microfluidizer under 100MPa pressure to emulsion breast even 8 times;
S08: add distilled water to 800ml;
S09: add collagen oligopeptide 320g, on water-bath evaporimeter (bath temperature 50 DEG C ± 1 DEG C), is stirred to dissolving;
S10: add distilled water to 1000ml on water-bath evaporimeter (bath temperature 50 DEG C ± 1 DEG C), stir, then filter packing, obtain and comprise the albumen oligopeptide (MW < 5000D) that concentration is 32%, and strengthening is with the strengthening protein oral liquor of nano liposomes vitamin C, nano liposomes vitamin E and zinc gluconate.
The high concentration strengthening protein oral liquor utilizing the embodiment of the present invention one to provide is tested:
One, materials and methods
1 test specimen
Oligopeptide nutritious protein liquid is prepared by method provided by the invention
2 animals used as test, grouping and hello oxygen method
2-1, experimental animal:
Male SD rat 30, body weight 180 ~ 200g, is provided by Peking University's experimental animal center.
2-2, test grouping: rat is divided into 3 groups at random after laboratory adapts to 3 days, that is: water group (control group A) is fed in normal diet+filling, Fish protein group (control group B) and the Fish protein of normal diet+30% oligomeric (MW < 5000D) are fed in normal diet+filling, fill with and feed (experimental group C), each treated animal body weight no significant difference.
2-3, feeding method
Rat is after Animal House adaptability feeds (recording the appetite of every rat during this), and C group rat fills with the Fish protein oligopeptide beverage 2mL feeding 30%, 1 time/d; B group rat fills with the fish protein drink 2mL feeding 30%, 1 time/d; The pure water of A group rat oral gavage equivalent.After all animal's diet balance 1 week, start to raise separately in stainless steel rat metabolism cage respectively.With the input standard that the average appetite (about 25g) of the minimum rat of food ration is the every daily diet of rats all during metabolic test, guarantee that the energy that every rat is taken in is mutually equal.Collect respectively, measure and process 72h excrement and urine, preserve with 20%H2SO4.
3, test index and method
3-1, application micro-Kjeldahl measure rat nitrogen metabolism.Get 0.2g/mL sample and the concentrated sulfuric acid, catalytic unit in kjeldahl flask, hot digestion on adjustable formula electric hot plate, until digestive juice from faint yellow fade to that pale blue is green clearly time, cooling, adding distil water dilutes, and is settled to 50mL; Get the digestive juice 3mL after dilution to distill in kjeldahl determination distilling apparatus, in bottle to be subjected, mixed liquor indicator fades to green by light gray redness, distillation 2min, mobile receiving flask, make to accept liquid level and leave the condensation mouth of pipe, continue distillation 1min, then use standard salt acidometric titration, terminal colour becomes light bois de rose by green, record hydrochloric acid consumption.Computing formula: daily sample nitrogen content=(sample consumes hydrochloric acid content-blank and consumes hydrochloric acid content) × 14 × concentration of hydrochloric acid × extension rate × daily sample total amount.
3-2 test index
Nitrogen balance=intake of nitrogen-excretion nitrogen quantity
Nitrogen storage rate=(intake of nitrogen-excretion nitrogen quantity)/intake of nitrogen
Nitrogen net utilization=nitrogen storage allowance/intake of nitrogen
Apparent digestibility=(intake of nitrogen-fecal nitrogen)/intake of nitrogen
3-3, statistical method
All data all represent with " average ± standard deviation ", though with CA2SIO fx-100 device and SPSS statistical package (one-wayANOVA) calculate, statistical analysis.Significance is P < 0.005.
Two, result and discussion
1,30% Fish protein oligopeptide is supplemented on the impact of rat nitrogen balance
Find in research, 3 treated animals are all in positive nitrogen equilibrium state.Contrast A group is fed normal diet+water, and its mean value is 01039 ± 01028; Contrast B group is fed normal diet+30% fish protein drink group, and playing a nitrogen balance value is 01453 ± 01013.Supplement 30% Fish protein oligopeptide rat nitrogen balance value the highest, after prompting supplements albumen oligopeptide, enter the nitrogen of body at most (as shown in table 1).
Table 1 supplements the impact of soybean oligopeptide on rat nitrogen balance:
2, soybean oligopeptide is supplemented on the impact of rat storage rate
Find in research, contrast A group feed+water, its nitrogen storage rate is 61093% ± 41247%; Contrast B group is fed normal diet+soybean protein isolate, and its nitrogen storage rate is 421128% ± 41494%; Normal diet+soybean oligopeptide and experimental group (C group) is fed, its nitrogen storage rate is 651968% ± 11827%; Supplement soybean oligopeptide group rat nitrogen storage rate the highest, higher by 56159% than supplementary soybean protein isolate group (P > 0105), nitrogen storage rate refers to that the nitrogen quantity that body stores accounts for total percentage taking in nitrogen, is also one of a kind of conventional index weighing internal metabolism.Nitrogen storage rate is high then illustrates that the retentivity of body to nitrogen is high, and the rat nitrogen storage rate of supplementing soybean oligopeptide group is the highest, and after soybean oligopeptide is taken in prompting, guarantor's nitrogen power of body significantly increases (as shown in table 2).
Table 2 supplements the impact of soybean oligopeptide on rat nitrogen storage rate
3,30% fish oligopeptide is supplemented on the impact of rat nitrogen net utilization
Find in research, contrast A group is fed normal diet+water, and its nitrogen net utilization is 91403% ± 61554%; Contrast B group is fed normal diet+30% Fish protein, and its nitrogen net utilization is 611412% ± 61824%; And experimental group (C group) normal diet of feeding+supplementing 30% fish oligopeptide, its nitrogen use efficiency is 961023% ± 21659%.Supplement 30% fish oligopeptide rat nitrogen net utilization the highest, higher by 56136% than supplementary Fish protein group (P > 0.105), than feeding water group high by 9211209% (P > 0105).Nitrogen net utilization refers to that clean nitrogen quantity accounts for total percentage taking in nitrogen.The nitrogen net utilization that body stores is high then illustrates that the utilization rate of body to nitrogen is high.The rat nitrogen net utilization supplementing 30% fish oligopeptide group is the highest, after prompting picked-up supplements 30% fish oligopeptide, body to the utilization of nitrogen more entirely, more thoroughly, therefore, supplements the standard (as shown in table 3) that 30% fish oligopeptide conforms with high-quality nitrogenous source.
Table 3 supplements 30% fish oligopeptide to the impact of rat nitrogen net utilization
4 discuss
Nitrogen substance in body has protein, amino acid, creatine, purine, pyrimidine, inosine, vitamin and amino sugar etc., and the nitrogen substance that wherein most important, metabolism is active, then nonprotein does not belong to.The nitrogen metabolism of usual body is identical with protein metabolism.And body is to the absorption of nitrogen, storage and utilization, then reflect the situation of body protein metabolism.Nitrogen balance weighs a kind of common counter of body internal protein metabolism, in fact refers to the contrast of body to nitrogen intake and discharge rate, namely take in nitrogen divided by excretion nitrogen.
The digestibility of protein is the degree that reflection food protein is digested, absorb.The percentage accounting for the nitrogen pool of absorption by the nitrogen quantity that body absorbs represents, namely (takes in nitrogen-fecal nitrogen)/takes in nitrogen.And the percentage that in body, the storage allowance of nitrogen accounts for total intake of nitrogen is the utilization rate of nitrogen.Certainly, the index of these reflection nitrogen metabolism is again the parameter weighing protein nutritive value height simultaneously.If the nitrogen quantity that a kind of absorptivity of protein is high, store is many, so it utilizes also complete, then the Functionality, quality and appealing design of this protein, is of high nutritive value.At present, about the idea that protein digestibility absorbs, tend to think under the digestive juice effect in alimentary canal (mainly small intestine) of protein in meals, resolve into oligopeptide (accounting for 2/3) and free amino acid, small peptide is then hydrolyzed into end-product small peptide further by the peptase of intestinal villi BBM (mainly aminopeptidase), small peptide then enters blood circulation by the peptide carrier cross-docking of intestinal villi BBM, enters tissue and participates in protein metabolism.Due to the existence of peptase in small intestinal cell BBM and cytosol, the polypeptide in enteric cavity is hydrolyzed into small peptide by aminopeptidase, and therefore, the direct absorption of small peptide becomes the principal mode that body takes in protein.
The present invention contains the albumen oligopeptide (MW < 5000D) of 30%, and strengthening is with nano liposomes vitamin C, nano liposomes vitamin E and zinc gluconate, ensure that the stability of vitamin, and improve albumen, the absorptivity of vitamin and bioavilability.Product appearance clear, thermodynamic stability are good, system is compatible good, can be widely used in the use of weak patient, perioperatively patient, clinical various diseases patient.
Below the effect describing component of the present invention, preparation method in detail in conjunction with the embodiments and reach, but embodiment is only, for demonstration, the present invention is described.Description is only for explaining claims.But protection scope of the present invention is not limited to description.Any those skilled in the art of being familiar with are in the technical scope that the present invention discloses, and the change that can expect easily or replacement, all should be encompassed within protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain of claims.
Claims (4)
1. strengthen a protein oral liquor, it is characterized in that, comprising: containing albumen oligopeptide, nano liposomes vitamin C, nano liposomes vitamin E and zinc gluconate.
2. strengthening protein oral liquor according to claim 1, is characterized in that, every 100 milliliters of oral liquids contain albumen oligopeptide, the vitamin E of 0.5 ~ 300mg, the vitamin C of 10 ~ 500mg, the zinc gluconate of 5-20mg of 30 ~ 35g.
3. strengthening protein oral liquor according to claim 2, is characterized in that, albumen oligopeptide molecular weight < 5000D.
4. strengthening protein oral liquor according to claim 3, is characterized in that, albumen oligopeptide is the hydrolysate of animal collagen, animal muscle protein or lactalbumin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410520351.5A CN104366511A (en) | 2014-10-08 | 2014-10-08 | High-density reinforced protein oral liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410520351.5A CN104366511A (en) | 2014-10-08 | 2014-10-08 | High-density reinforced protein oral liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104366511A true CN104366511A (en) | 2015-02-25 |
Family
ID=52545902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410520351.5A Pending CN104366511A (en) | 2014-10-08 | 2014-10-08 | High-density reinforced protein oral liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104366511A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106036916A (en) * | 2016-06-02 | 2016-10-26 | 王斐芬 | Postoperative repairing nutriment |
CN106889619A (en) * | 2017-03-06 | 2017-06-27 | 青岛海大华旗生物科技有限公司 | It is a kind of to promote health food of post-operative recovery and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103844273A (en) * | 2014-03-07 | 2014-06-11 | 禄美生物科技(上海)有限公司 | Collagen oral solution and preparation method thereof |
-
2014
- 2014-10-08 CN CN201410520351.5A patent/CN104366511A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103844273A (en) * | 2014-03-07 | 2014-06-11 | 禄美生物科技(上海)有限公司 | Collagen oral solution and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106036916A (en) * | 2016-06-02 | 2016-10-26 | 王斐芬 | Postoperative repairing nutriment |
CN106889619A (en) * | 2017-03-06 | 2017-06-27 | 青岛海大华旗生物科技有限公司 | It is a kind of to promote health food of post-operative recovery and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107348294B (en) | Cubilose collagen solid beverage and preparation method thereof | |
CN101530195B (en) | Food formula of special diet containing oligopeptides for maternity patient | |
CN101272793B (en) | Sphingomyelin-containing medicine, food and drink or fodder | |
CN101422239B (en) | Combined partner capable of increasing edible rice, flour nutrition | |
CN110214940A (en) | A kind of full nutrition special medicine purposes formula nutritional liquid of adult and preparation method thereof | |
CN103284039A (en) | Weight-reducing composition and preparation method thereof | |
CN107951015A (en) | Full nutrient formulation powder and preparation method thereof | |
CN101696444B (en) | Polypeptide extract as well as preparation method and application thereof | |
CN103844273B (en) | Collagen oral solution and preparation method thereof | |
CN101642165B (en) | Method for preparing weight-reducing yoghurt beverage | |
CN102048225B (en) | Red-date health protection beverage capable of improving growing development | |
CN103735556B (en) | A kind of multi-vitamin mineral composite effervescent sheet and preparation method | |
CN106360243A (en) | White fungus composite solid beverage having anti-oxidation function and preparation method of white fungus composite solid beverage | |
CN104366511A (en) | High-density reinforced protein oral liquid | |
CN108208798A (en) | Full nutrient formulation liquid and preparation method thereof | |
CN104642958A (en) | Chinese yam and matrimony vine powder, and preparation method thereof | |
CN103621871B (en) | Compound amino acid health-care product and preparation method thereof | |
CN110604295A (en) | Composite bone peptide and preparation method thereof | |
CN103478718B (en) | Improve functional food of glutathione concentration in human body and preparation method thereof | |
CN101524153A (en) | Health-care wheat flour beneficial for diabetes patients | |
CN107950935A (en) | A kind of bird's nest ferment | |
CN108851037A (en) | A kind of preparation method and its usage of nephrotic syndrome wholefood | |
CN1788578A (en) | Preparation method of fat-reducing blood sugar-reducing sour soybean milk containing micro pine pollen,konnjaku powder | |
CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
KR20090110423A (en) | Use of heme-iron polypeptide as iron supplement in beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150225 |